CURRICULUM VITAE

August 2007

 

Joseph C. Cappelleri, Ph.D., M.P.H., M.S.

 

Office:                                                                                    

Pfizer Inc                                                                                

Global Research & Development                                      

MS 8260-2222                                                                                 

Eastern Point Road                                                             

Groton, CT 06340

 

e-mail: joseph.c.cappelleri@pfizer.com

tel.: (860) 441-8668                                                             

fax: (860) 441-8751                                                 

                                                             

 EDUCATION

 

            Graduate

            1993     M.P.H. (Epidemiology), Harvard University, Cambridge, MA (GPA=3.9)

            1991     Ph.D. (Psychometrics), Cornell University, Ithaca, NY (GPA=4.0)

            1986     M.S. (Statistics), City University of New York (Baruch College), NY (GPA=3.8)        

           

            Undergraduate

1984      B.B.A. (Finance), City University of New York (Baruch College), NY (GPA=3.8)

 

           

WORK EXPERIENCE

                       

                                    Pfizer Inc, Global Research & Development, Groton, CT

 1/04 – present                      Director, Statistical Scientist, Biostatistics

 12/02 – 12/03                       Senior Associate Director, Statistical Scientist, Biostatistics                

 2/00  – 11/02                        Associate Director II, Biostatistics

 2/98  – 1/00              Associate Director I, Biostatistics 

 6/96  – 1/98              Senior Coordinator, Biostatistics

          Provide statistical and methodological consulting and advising -- manuscripts,  presentations, design & analysis, internal reports, analysis plans, teaching and moderating workshops, collaborations with clinicians & biostatisticians -- across therapeutic areas and phases of drug development in health services and outcomes research

 

 8/03 – present          Adjunct Faculty Member in Statistics

                                    Department of Statistics, University of Connecticut, Storrs, CT

 Teach semester-long graduate courses on epidemiology and longitudinal analysis as well as supervise students and collaborate with students

 

 

                       

10/96 – present         Adjunct Faculty Member in Medicine

                                    Department of Medicine, Division of Clinical Care Research,

                                    Tufts University School of Medicine, Boston, MA

                         Collaborate with faculty, supervise students, and lecture 

           

3/93 - 6/96                 Research Associate and Assistant Professor of Medicine

                                    New England Medical Center and Tufts University School of Medicine, Department of Medicine, Division of Clinical Care Research, Boston, MA

                         Involved with the development and management of the Real-Time Meta-Analysis System -- a systematic approach and computer software to organize, display, and utilize data from randomized control trials to perform meta-analysis efficiently -- for pharmaceuticals agents that cover antibiotic usage, hypertension, congestive heart failure, and AIDS

                         Involved with meta-analyses to evaluate the efficacy and safety of drugs that cover infectious (including AIDS), cardiovascular, and cerebrovascular diseases

                         Involved with statistical and methodological issues in meta-analysis

                         Presented lectures on meta-analysis to post-doctoral fellows

 

2/92 - 9/92                 Research Associate, Technology Assessment Group, Harvard School of Public Health, Boston, MA

                         Prepared a meta-analysis on the relative efficacy and safety of                                                                     different aspirin dosages on vascular events

 

1/90 - 9/91                 Research Support Specialist

                                    National Data Archive on Child Abuse & Neglect, Cornell University,                                        Ithaca, NY

                         Provided statistical and technical support on the Second National Incidence and                                      Prevalence Study of Child Abuse & Neglect

                         Worked with complex survey data analyzed with the programs WESVAR                                       WESREG, and WESLOG; used large data tapes, SAS, and the VM/MVS                                          and VM/CMS computer operating system

 

 
AWARDS, HONORS, AND RECOGNITION

           

2007               Coauthored article (Allison et al. American Journal of Psychiatry. 1999; 156:1686-1696) ranked as the sixth most cited article ever in the American Journal of Psychiatry. 

            2007               Exceptional psychometric validation on patient-reported outcomes (including the Erection Hardness Scale) in erectile dysfunction (Pfizer Inc)

            2007               Outstanding psychometric validation on patient-reported outcomes in obesity (Pfizer Inc)

2007               Interviewed in Doctor’s Guide to the Internet article “Sunitinib (Sutent) Improves Quality of Life over Interferon-Alfa in Kidney Cancer” based on conference presentation.

            2006               Interviewed in Pfizer Press Release on “New Data Suggest Pfizer’s Varenicline Reduces Craving and Withdrawal Symptoms Associated with Quitting Smoking and Decreases Satisfaction and Reward from Smoking” for delivering conference presentations

            2006               Interviewed in Blackwell Publishing Press Release on “Erection Pill Associated with Normalization of Relationships and Self-Esteem in Men with Erectile Dysfunction” as lead author on journal article

            2006               Leadership, support, and leadership for the Hierarchical and Survival Models Workshops at Pfizer Inc

2005               Research Fellow, Center for Healthcare & Insurance Studies, University of Connecticut, Storrs, CT

            2005               Coauthored article (Rosenstock et al. Diabetes Care. 2004; 27:1318-1323)

                                                selected for the Yearbook of Endocrinology 2005 that brings together abstracts of articles that reported the year’s breakthrough developments in endocrinology (In: Mazzaferri EL, ed. Yearbook of Endocrinology 2005. Philadelphia, PA: Elsevier)

            2005               Leadership, support, and teamwork for the Applied Longitudinal Analysis Workshops at Pfizer Inc

            2005               Leadership and team building for presenting 5-hour workshop on meta-analysis to Outcomes Research Group at Pfizer Inc

            2005               Statistical and methodological contributions in developing and validating an instrument for early onset for patients with generalized anxiety disorder (Pfizer Inc)

            2004               Leadership in and teaching of Item Response Theory Seminar Series to colleagues in Outcomes Research at Pfizer Inc

            2004               Regulatory support of Femhrt (Pfizer Inc)

            2004               Analysis and strategy in support of Celebrex (Pfizer Inc)

            2003               Tireless efforts, enthusiasm, and productive collaborations in support of Outcomes Research at Pfizer Inc

            2003               Psychometric analyses of data on smoking cessation (Pfizer Inc)

2002               Leadership, teamwork, and contributions to support Femhrt skin aging program and Zoloft (Pfizer Inc)

2001               Interviewed in book “Viagra: The remarkable story of the discovery and launch” (by Larry Katzenstein, New York: Medical Information Press, 61-62)

            2001               Outstanding performance in teaching Modern Psychometric Workshop and Clinical Significance Workshop (Pfizer Inc)

2001               Excellence in overall statistical support to Outcomes Research (Pfizer Inc)

            2001               Teamwork and leadership in support of Biometrics support to Ann Arbor’s Outcomes Research development (Pfizer Inc)

2001                              Major contributions to inhaled insulin program: Phase 2 (Pfizer Inc)

2001               Major contributions to inhaled insulin program: Phase 3 (Pfizer Inc)

            1995               Special and Scientific Staff, Tufts University

            1991               Cancer Epidemiology Fellowship, Harvard University

            1990               Phi Kappa Phi, Cornell University Chapter

            1986               Rosenkranz-Goldstein Award for Excellence in Statistics

            1984               Magna Cum Laude

            1984               Baruch Alumni Scholarship

            1983               Beta Gamma Sigma

 

PROFESSIONAL AFFILIATIONS

 

International Society for Quality of Life Research

·   Pharmaceutical Research and Manufacturers of America

·   American Statistical Association

            Drug Information Association

            International Society for Pharmacoeconomics and Outcomes Research

International Chinese Statistical Association

            Society for Clinical Trials

            Society for Medical Decision Making

                                   

 

SUBJECTS TAUGHT  

 

·                 Instructor on graduate statistics course “Applied Longitudinal Analysis” to students at the University of Connecticut, Storrs (spring 2006 semester, January 17 – April 28).

·              Instructor on graduate statistics course “Introduction to Epidemiology” to students at the University of Connecticut, Storrs (spring 2004 semester, January 20 – April 30; spring 2005 semester, January 18 – April 29; spring 2007 semester, January 16 – April 27).

·              Instructor on “An Overview of Outcomes Research” and “An Overview of the International Index of Erectile Function” in a managerial statistics seminar at Rensselaer Polytechnic Institute (three-hour lecture, Groton, Connecticut, November 7, 2003)

·                    Instructor on “Applying the Rasch Model’ (seminar to Pfizer employees, Groton, CT, January - June 2003)

·                    Instructor on “Meta-Analysis and Systemic Literature Review – Introduction” (four-hour short course at the Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research: Arlington, Virginia, May 20-23, 2001; May 19-22, 2002; May 18-21, 2003; May 16-19, 2004; Washington, DC, May 15-18, 2005. Pfizer Inc, New London, CT, May 21-22, 2003 and June 22, 2004, Pfizer Inc, New York, NY, March 29, 2005)

·                    Instructor on “Introduction to Meta-Analysis” in clinical trials course at the University of Connecticut, Storrs (two 3-hour lectures, April 16 and 23, 2003; 3-hour lecture, November 15, 2004)

·                    Instructor on “Sample Size Estimation in Outcomes Research” (four-hour short course to Pfizer employees in Ann Arbor, MI, October 17, 2001; Groton/New London, CT, May 15, June 21, 2003)

·                    Instructor on “Introduction to Business Statistics” (spring 1987 and summer 1987 to Baruch undergraduates)

·                    Teaching assistant on “Measurement in Program Evaluation & Research” (fall 1988 to Cornell graduate students)

·                    Teaching assistant on “Program Evaluation & Research Design” (spring 1989 to Cornell graduate students)

·                    Teaching assistant on “Statistics and the World We Live In” (spring 1988 to Cornell undergraduate)

 

 

 

FORMER RESEARCH SUPPORT                     

 

            Contract: University of Illinois at Chicago

                                    National Research and Training Center on Psychiatric Disability                       Amount: $53,000         

            Period: 9/1995 - 6/1996    

            Role: Statistical Consultant

           

            Grant Title: Comparative Outcomes of Ambulatory Pharmaceutical Agents

            Funding Agency: Agency for Health Care Policy and Research

            Amount: $1.2 million                      

            Period: 3/1993 - 3/1996    

            Role: Co-Investigator

 

 

EDITORIAL ACTIVITY

 

2007                                                   Reviewer, Reading First Impact Study, Interim Report; “No Child Left Behind” (U.S. Department of Education)

2007                                                   Reviewer, Addictive Behaviors

2006-2007                                         Reviewer, Pharmaceutical Statistics

2001-2007                                         Reviewer, Quality of Life Research

1998-2007                                         Editorial Board and Reviewer, Drug Information Journal

2005-2007                                         Editorial Board and Reviewer, Asian Journal of Andrology

2001-2004, 2006-2007                    Reviewer, Value in Health

2001-2002, 2004-2007                    Reviewer, Medical Care

2004-2007                                         Reviewer, International Journal of Impotence Research

2006                                                   Reviewer, National Evaluation of Early Reading First, “No Child Left Behind” (U.S. Department of Education)

2006                                                   Reviewer, Drug and Alcohol Dependence

2006                                                   Reviewer, Dose Findings in Drug Development (N Ting, editor; NY: Springer-Verlag, 2006)

2005-2006                                                                                  Reviewer, Clinical Trials      

2001, 2004-2006                              Reviewer, Statistics in Medicine

1994, 2000-2003, 2005-2006                     Reviewer, Diabetes Care

2003-2004